Universal Vision Biotechnology Statistics
Total Valuation
Universal Vision Biotechnology has a market cap or net worth of TWD 18.43 billion. The enterprise value is 17.97 billion.
Market Cap | 18.43B |
Enterprise Value | 17.97B |
Important Dates
The next estimated earnings date is Monday, November 11, 2024.
Earnings Date | Nov 11, 2024 |
Ex-Dividend Date | Apr 18, 2024 |
Share Statistics
Universal Vision Biotechnology has 84.72 million shares outstanding. The number of shares has increased by 0.08% in one year.
Shares Outstanding | 84.72M |
Shares Change (YoY) | +0.08% |
Shares Change (QoQ) | -0.08% |
Owned by Insiders (%) | 26.82% |
Owned by Institutions (%) | 13.62% |
Float | 46.86M |
Valuation Ratios
The trailing PE ratio is 16.77 and the forward PE ratio is 15.56.
PE Ratio | 16.77 |
Forward PE | 15.56 |
PS Ratio | 4.42 |
PB Ratio | 5.87 |
P/FCF Ratio | 16.44 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.83, with an EV/FCF ratio of 16.03.
EV / Earnings | 16.32 |
EV / Sales | 4.31 |
EV / EBITDA | 9.83 |
EV / EBIT | 13.27 |
EV / FCF | 16.03 |
Financial Position
The company has a current ratio of 2.53, with a Debt / Equity ratio of 26.39.
Current Ratio | 2.53 |
Quick Ratio | 2.16 |
Debt / Equity | 26.39 |
Debt / EBITDA | 0.47 |
Debt / FCF | 0.77 |
Interest Coverage | 80.64 |
Financial Efficiency
Return on equity (ROE) is 35.64% and return on invested capital (ROIC) is 21.61%.
Return on Equity (ROE) | 35.64% |
Return on Assets (ROA) | 16.86% |
Return on Capital (ROIC) | 21.61% |
Revenue Per Employee | 10.39M |
Profits Per Employee | 2.75M |
Employee Count | 401 |
Asset Turnover | 0.83 |
Inventory Turnover | 5.95 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.08% in the last 52 weeks. The beta is 0.75, so Universal Vision Biotechnology's price volatility has been lower than the market average.
Beta (5Y) | 0.75 |
52-Week Price Change | -33.08% |
50-Day Moving Average | 231.91 |
200-Day Moving Average | 261.13 |
Relative Strength Index (RSI) | 38.80 |
Average Volume (20 Days) | 179,026 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Universal Vision Biotechnology had revenue of TWD 4.17 billion and earned 1.10 billion in profits. Earnings per share was 12.97.
Revenue | 4.17B |
Gross Profit | 2.50B |
Operating Income | 1.35B |
Pretax Income | 1.37B |
Net Income | 1.10B |
EBITDA | 1.66B |
EBIT | 1.35B |
Earnings Per Share (EPS) | 12.97 |
Balance Sheet
The company has 1.46 billion in cash and 866.02 million in debt, giving a net cash position of 597.91 million or 7.06 per share.
Cash & Cash Equivalents | 1.46B |
Total Debt | 866.02M |
Net Cash | 597.91M |
Net Cash Per Share | 7.06 |
Equity (Book Value) | 3.28B |
Book Value Per Share | 37.08 |
Working Capital | 1.44B |
Cash Flow
In the last 12 months, operating cash flow was 1.54 billion and capital expenditures -422.07 million, giving a free cash flow of 1.12 billion.
Operating Cash Flow | 1.54B |
Capital Expenditures | -422.07M |
Free Cash Flow | 1.12B |
FCF Per Share | 13.23 |
Margins
Gross margin is 60.03%, with operating and profit margins of 32.52% and 26.44%.
Gross Margin | 60.03% |
Operating Margin | 32.52% |
Pretax Margin | 32.93% |
Profit Margin | 26.44% |
EBITDA Margin | 39.89% |
EBIT Margin | 32.52% |
FCF Margin | 26.92% |
Dividends & Yields
This stock pays an annual dividend of 7.00, which amounts to a dividend yield of 3.22%.
Dividend Per Share | 7.00 |
Dividend Yield | 3.22% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 10 |
Payout Ratio | 97.41% |
Buyback Yield | -0.08% |
Shareholder Yield | 3.14% |
Earnings Yield | 5.96% |
FCF Yield | 6.08% |
Stock Splits
The last stock split was on August 25, 2023. It was a forward split with a ratio of 1.06.
Last Split Date | Aug 25, 2023 |
Split Type | Forward |
Split Ratio | 1.06 |